Cogniciti is a private sector digital health firm formed in 2010 to help reshape the world of brain health.
Our point of difference: a focus on and expertise in cognitive science. Cogniciti's majority owner, Baycrest, is Canada's largest geriatric healthcare institute and a world leader in the research of memory and aging. Our minority owner, MaRS, is a Canadian leader in converting science and technology research into practical solutions.
Our mission is to use our expertise to bring brain health solutions to people, businesses, and governments around the globe. These solutions are badly needed to help the millions of adults with significant memory concerns get earlier assessment, diagnosis and treatment. To help the tens of millions of adults with normal memory loss find peace-of-mind and effective coping tools. To help family caregivers better support loved ones with dementia. And to speed the development of the next generation of dementia drugs.
We're producing results. Like our online, clinically researched Brain Health Assessment that has helped more than 60,000 adults answer the question, "Is my memory normal or should I see my doctor?" And our Research Registry which is finding badly needed volunteers for brain health studies being led by global pharmaceutical manufacturers and other research-driven organizations.
Support for our work has been terrific. We've attracted more than 1,000 volunteers to our research programs, been awarded major funding grants from both the Canadian and Ontario governments, and won numerous healthcare innovation awards.
Located on a 22-acre campus in Toronto, Canada, Baycrest is one of the world's leading academic health sciences centres focused on aging.
Baycrest continues to attract some of the most influential scientists in aging and cognition and is a laboratory for unparalleled innovation in clinical care delivery to an aging population.
Baycrest's Research Centre for Aging and the Brain includes the acclaimed Rotman Research Institute, considered one of the top five brain institutes in the world, and the Kunin-Lunenfeld Applied and Evaluative Research Unit (KLAERU), which conducts research alongside clinicians and applies the results directly to client care.
MaRS Discovery District is a large-scale, mission-driven innovation centre located in Toronto and networked across Ontario, focused on building Canada's next generation of technology companies. MaRS works closely with entrepreneurs to grow and scale their ventures into global market leaders in life sciences and health care, information, communications and digital media technologies, cleantech, advanced materials and engineering, as well as innovative social purpose businesses.
Cambridge Brain Sciences (CBS) is a world leader in providing scientifically proven web-based tools for the assessment of cognitive function.
The CBS concept was developed by Doctors Adrian Owen and Adam Hampshire during their time at the MRC Cognition and Brain Sciences Unit in Cambridge England. CBS has since moved to the Brain and Mind Institute at Western University in London Ontario Canada where development of web-based assessment platforms is focused in two areas: a) scientific investigation including clinical and pharmaceutical trials and b) tools that allow members of the public to assess their memory, attention, reasoning and planning. More than 200,000 CBS assessments have been completed on adults across the globe and dozens of research trials are currently taking place using the CBS platform.